Concepedia

Lymor Ringer

LR

Statistics

Publications

8

Citations

542

H-Index

8

Active since

2010

Affiliations

Georgetown University Medical Center(Current)

Georgetown University

Thomas Jefferson University

Sidney Kimmel Cancer Center

Children's National

Lymor Ringer is an author at Georgetown University Medical Center specializing in oncology, molecular oncology, and medicine.

Publications per year

2010–2019

8

Publications

8

Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway

Elspeth M. Beauchamp, Lymor Ringer, Gülay Bulut et al. · Journal of Clinical Investigation · 2010 · 347 citations · Full text

Medicine, Cancer Biology, Oncology +17

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.

Claire B. Pollock, Sara McDonough, Hyojung Lee et al. · Oncotarget · 2014 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells

Lymor Ringer, Paul Sirajuddin, Lucas Tricoli et al. · Oncotarget · 2014 · 42 citations · Full text

Life Sciences, Cell Biology, Oncology +17

VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells

Lymor Ringer, Paul Sirajuddin, Venkata Mahidhar Yenugonda et al. · Cancer Biology & Therapy · 2010 · 21 citations · Full text

Life Sciences, Oncology, Pharmacology +17

VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells

Lymor Ringer, Paul Sirajuddin, Mary Mazzotta Heckler et al. · Cancer Biology & Therapy · 2011 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 8